Revvity, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Revvity, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $26 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 95% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 5.4 times. Higher than 88% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$108Over the last 3 years, every $100 of reported profit came with $108 of operating cash.
Lower than 80% of Healthcare companies in United States.
Self-Funding Ratio
5.4×Over the last 3 years its own operating cash covered its investment spending (capex) 5.4 times.
Higher than 88% of Healthcare companies in United States.
Cash Locked Ratio
$30For every $100 of sales, $30 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $21 tied up three years earlier.
More money tied up than 66% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 14%
Sales fell 14% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-14% / -14%In 3 years sales changed by -14% while total assets changed by -14%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
1.0×Debt due within a year is covered 1.0 times by its yearly operating cash.
Higher than 72% of Healthcare companies in United States.
Cash Cushion Ratio
−14%Debt, after subtracting cash, equals 14% of its market value (net debt).
Lower than 81% of Healthcare companies in United States.
Tangible Assets Ratio
26%Of every $100 the company owns, $26 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 95% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 80% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Revvity, Inc. owes $0.40 for every $1 it owns. Net profit fell 11% in the year to Dec 2025, and shrank 25% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
75.3Investors pay $75.3 for every $1 of Revvity, Inc.'s yearly profit, higher than 86% of Healthcare companies in United States.
P/B ratio
2.43The share price is 2.43 times Revvity, Inc.'s book value per share, lower than 52% of Healthcare companies in United States.
Market cap
$17.6 BThe total market value of all of Revvity, Inc.'s shares at today's price (share price × number of shares), larger than 93% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$7.2 BWhat Revvity, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$64.78Net worth divided by the number of shares. The share price of $157.36 is 2.4 times this, which is the P/B above.
Return on equity (ROE)
3.2%Revvity, Inc. earned 3.2% on its shareholders' money over the last year, higher than 79% of Healthcare companies in United States.
Owes vs Owns
0.40×Revvity, Inc. owes $0.40 for every $1 it owns (low), lower than 51% of Healthcare companies in United States.
Dividend yield
0.18%Revvity, Inc. pays 0.18% of its share price as dividends a year, lower than 96% of dividend-paying Healthcare companies in United States.
Revenue growth
+4%Revenue rose 4% in the year to Dec 2025, and shrank 5% a year on average over 3 years.
Profit growth
-11%Net profit fell 11% in the year to Dec 2025, and shrank 25% a year on average over 3 years.
Profit margin
8.4%Revvity, Inc. keeps $8 of every $100 of revenue as net profit.
Cash quality
2.4×Cash from Revvity, Inc.'s business was 2.4× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
3.9×Revvity, Inc.'s operating profit covered its interest costs 3.9 times in the year to Dec 2025.
Cash vs debt
Net debtRevvity, Inc. had $2.5 B more debt than cash (net debt) at Dec 2025.
Questions
What is Revvity, Inc.'s P/E ratio?
Investors pay $75.3 for every $1 of Revvity, Inc.'s yearly profit, higher than 86% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Revvity, Inc.: $17.6 B ÷ $7.2 B (30 Jun 2026) = 2.4.
What is Revvity, Inc.'s return on equity?
Revvity, Inc. earned 3.2% on its shareholders' money over the last year, higher than 79% of Healthcare companies in United States.
How much does Revvity, Inc. owe compared with what it owns?
Revvity, Inc. owes $0.40 for every $1 it owns (low), lower than 51% of Healthcare companies in United States.
Does Revvity, Inc. pay a dividend?
Yes. Revvity, Inc. pays 0.18% of its share price as dividends a year, lower than 96% of dividend-paying Healthcare companies in United States.
Is Revvity, Inc.'s revenue growing?
Revenue rose 4% in the year to Dec 2025, and shrank 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.